ISOLATION OF STEM CELLS FOR THE KIDNEY AND EXPERIMENTAL TRIAL FOR THE REGENERATIVE MEDICINE

肾脏干细胞的分离及再生医学的实验研究

基本信息

  • 批准号:
    13470211
  • 负责人:
  • 金额:
    $ 9.47万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

Using transgenic rats which express GFP (Green Fluorescent Protein) throughout the body, we established chimeric rats which carry GFP(+) cells in all progeny of bone marrow. This system allowed us to find that bone marrow-derived cells contributed to the regeneration of mesangial cell in a self limiting acute glomerulonephritis model. We also showed that bone mar row cells were able to differentiate into mesangial cells in vitro. Both in vivo and in vitro, Platelet-derived growth factor-B was critical for the generation of bone marrow-derived mesangial cells. We also established a method to purify precursor cells/stem cells for mesangial cells from crude bone marrow preparation by using an unwoven mesh filter system. We purified side population (SP) cells from adult rat kidneys, and characterized them. In short, we proved that SP cells were not the stem cells for mesangial cells or tubular epithelial cells even though they clearly existed in the kidney. In order to find genes which are critical for the nephrogenesis, we compared a set of RNA obtained from neonatal rat kidneys to another set of RNA obtained from adult rat kidneys. By the suppression subtractive hybridization method, we found that retinaldehyde dehydrogenase type 2 (RALDH2) was highly enriched in the comma-shaped body and S-shaped body, and that RALDH2 was upregulated during the differentiation of glomerular epithelial cells. We also developed a new method which allows us to purify RNA from the nephrogenic zone of neonatal rat kidneys. Our extensive analysis revealed that the local concentration of retinoic acid that is produced by RALDH2 plays a critical role to repair injured podocytes, and that retinoic acid directly regulates the transcription of nephrin. Our further analysis about RALDH2 and other newly identified genes are under way.
使用全身表达GFP(绿色荧光蛋白)的转基因大鼠,我们建立了在所有骨髓后代中携带GFP(+)细胞的嵌合大鼠。这一系统使我们能够发现骨髓来源的细胞在自限性急性肾小球肾炎模型中有助于系膜细胞的再生。我们还发现骨髓细胞在体外能够分化为系膜细胞。无论在体内还是体外,血小板源性生长因子-B对骨髓源性系膜细胞的生成都是至关重要的。我们还建立了一种方法,纯化前体细胞/干细胞的系膜细胞从粗骨髓制备,通过使用无纺网过滤系统。我们纯化侧群(SP)细胞从成年大鼠肾脏,并进行了表征。总之,我们证明了SP细胞不是系膜细胞或肾小管上皮细胞的干细胞,尽管它们明确存在于肾脏中。为了找到对肾发生至关重要的基因,我们比较了从新生大鼠肾脏获得的一组RNA和从成年大鼠肾脏获得的另一组RNA。通过抑制性消减杂交技术,我们发现2型视黄醇脱氢酶(RALDH 2)在肾小球S形小体和逗号小体中高度富集,并且在肾小球上皮细胞分化过程中RALDH 2表达上调。我们还开发了一种新的方法,使我们能够从新生大鼠肾脏的肾区纯化RNA。我们广泛的分析表明,由RALDH 2产生的视黄酸的局部浓度对修复受损的足细胞起着关键作用,并且视黄酸直接调节nephrin的转录。我们对RALDH 2和其他新发现的基因的进一步分析正在进行中。

项目成果

期刊论文数量(122)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ito T, Suzuki A, Okabe M, Imai E, et al.: "Application of bone marrow derived stem cells in experimental nephrology"Exp Nephrol. 9. 444-450 (2001)
Ito T、Suzuki A、Okabe M、Imai E 等人:“骨髓干细胞在实验肾病学中的应用”Exp Nephrol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Imai E.: "Gene therapy approach in renal disease in the 21st century"Nephrol Dial Transplant. 16 Suppl 5. 26-34 (2001)
Imai E.:“21 世纪肾脏疾病的基因治疗方法”肾拨号移植。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Isaka Y, Imai E.: "Future strategy: gene therapy for diabetic nephropathy"Contrib Nephrol. 127-132 (2001)
Isaka Y、Imai E.:“未来策略:糖尿病肾病的基因治疗”Contrib Nephrol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ito T, Suzuki A, Imai E, et al.: "Tornado extraction : a method to enrich and purify RNA from the nephrogenic zone of the neonatal rat kidney"Kidney Int. 62. 763-769 (2002)
Ito T、Suzuki A、Imai E 等人:“龙卷风提取:一种从新生大鼠肾脏的肾源区富集和纯化 RNA 的方法”Kidney Int。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Horio M, Ito A, Matsuoka Y, Moriyama T, et al.: "Apoptosis induced by hypertonicity in Madin Darley canine kidney cells : protective effect of betaine"Nephrol Dial Transplant. 16. 483-490 (2001)
Horio M、Ito A、Matsuoka Y、Moriyama T 等人:“Madin Darley 犬肾细胞高渗诱导的细胞凋亡:甜菜碱的保护作用”肾移植。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IMAI Enyu其他文献

IMAI Enyu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IMAI Enyu', 18)}}的其他基金

Gene expression profile of tonsils of patients with IgA nephropathy
IgA肾病患者扁桃体基因表达谱
  • 批准号:
    20590957
  • 财政年份:
    2008
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification and characterization of stem cells for kidney
肾脏干细胞的鉴定和表征
  • 批准号:
    15390270
  • 财政年份:
    2003
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Characterization of a novel aspartic proteinase and development of its inhibitor
新型天冬氨酸蛋白酶的表征及其抑制剂的开发
  • 批准号:
    12557085
  • 财政年份:
    2000
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Gene therapy for progressive renal diseases
进行性肾病的基因治疗
  • 批准号:
    10470217
  • 财政年份:
    1998
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Development of Gene Therapy for Progrssive Glomerular Diseases
进展性肾小球疾病基因疗法的发展
  • 批准号:
    08457288
  • 财政年份:
    1996
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Identification and impact of polymers on stem cell products in an automated biomanufacturing platform
自动化生物制造平台中聚合物对干细胞产品的识别和影响
  • 批准号:
    10089013
  • 财政年份:
    2024
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Collaborative R&D
Bio-inspired Nanoparticles for Mechano-Regulation of Stem Cell Fate
用于干细胞命运机械调节的仿生纳米颗粒
  • 批准号:
    DP240102315
  • 财政年份:
    2024
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Discovery Projects
Engineering the bone marrow niche to control stem cell regulation, metastatic evolution and cancer dormancy
改造骨髓生态位来控制干细胞调节、转移进化和癌症休眠
  • 批准号:
    EP/X036049/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Research Grant
The effects of human lower limb immobilization on regenerative skeletal muscle stem cell characteristics in vitro
人体下肢固定对体外再生骨骼肌干细胞特性的影响
  • 批准号:
    MR/Y033787/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Research Grant
CAREER: Mechano-Metabolic Control of Electrical Remodeling of Human Induced Pluripotent Stem Cell Derived Engineered Heart Muscle
职业:人类诱导多能干细胞衍生的工程心肌电重塑的机械代谢控制
  • 批准号:
    2338931
  • 财政年份:
    2024
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Standard Grant
腸脳相関によるサイトカインを中心とした膠芽腫Cancer Stem Cell Theoryの解明
通过肠-脑相关性阐明以细胞因子为中心的胶质母细胞瘤癌症干细胞理论
  • 批准号:
    24K12244
  • 财政年份:
    2024
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Exploring multidisciplinary approaches from Stem Cell Biology and Microengineering to biomanufacture perfused organoids
探索从干细胞生物学和微工程到生物制造灌注类器官的多学科方法
  • 批准号:
    BB/W018470/2
  • 财政年份:
    2024
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Research Grant
Pluripotent stem cell derived hepatocytes for liver failure (PUSH for LIFE)
多能干细胞衍生的肝细胞治疗肝衰竭(PUSH for LIFE)
  • 批准号:
    MR/Z503940/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Research Grant
ERI: Mechanistic understanding of neural stem cell paracrine activity and extracellular vesicle secretion directed by wireless electrical stimulation
ERI:无线电刺激引导的神经干细胞旁分泌活性和细胞外囊泡分泌的机制理解
  • 批准号:
    2301908
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Standard Grant
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
  • 批准号:
    23K07844
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了